BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 7892561)

  • 1. [Treatment of idiopathic pulmonary fibrosis].
    Nicod LP
    Schweiz Med Wochenschr; 1995 Mar; 125(10):483-8. PubMed ID: 7892561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recognition and treatment of idiopathic pulmonary fibrosis.
    Nicod LP
    Drugs; 1998 Apr; 55(4):555-62. PubMed ID: 9561344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Long-term follow-up of lung function parameters in patients with idiopathic pulmonary fibrosis treated with prednisone and azathioprin or d-penicillamine (author's transl)].
    Meier-Sydow J; Rust M; Kronenberger H; Thiel C; Amthor M; Riemann H
    Prax Klin Pneumol; 1979 Apr; 33 Suppl 1():680-8. PubMed ID: 461366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Idiopathic pulmonary fibrosis; description of a Dutch cohort].
    Barlo NP; van Moorsel CH; van den Bosch JM; van de Graaf EA; Kwakkel-van Erp JM; Grutters JC
    Ned Tijdschr Geneeskd; 2009; 153():B425. PubMed ID: 19785823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exercise testing in interstitial lung disease.
    Kelley MA; Daniele RP
    Clin Chest Med; 1984 Mar; 5(1):145-56. PubMed ID: 6723237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of cyclosporine to reduce steroids in patients with idiopathic pulmonary fibrosis before lung transplantation.
    Venuta F; Rendina EA; Ciriaco P; De Giacomo T; Pompeo E; Bachetoni A; Ricci C
    J Heart Lung Transplant; 1993; 12(6 Pt 1):909-14. PubMed ID: 8312314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy of ab initio immunosuppressive therapy and steroid-sparing effect in interstitial lung disease associated with antisynthetase antibody syndrome].
    Franzolini N; Quartuccio L; De Marchi G; De Vita S
    Reumatismo; 2007; 59(3):202-8. PubMed ID: 17898879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colchicine, cyclophosphamide and prednisone in the treatment of mild-moderate idiopathic pulmonary fibrosis: comparison of three currently available therapeutic regimens.
    Fiorucci E; Lucantoni G; Paone G; Zotti M; Li BE; Serpilli M; Regimenti P; Cammarella I; Puglisi G; Schmid G
    Eur Rev Med Pharmacol Sci; 2008; 12(2):105-11. PubMed ID: 18575160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pulmonary toxicity of drugs and thoracic irradiation in children].
    Fauroux B; Clément A; Tournier G
    Rev Mal Respir; 1996 Jul; 13(3):235-42. PubMed ID: 8765915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in interstitial lung disorders.
    Wesselius LJ
    Compr Ther; 1984 May; 10(5):27-34. PubMed ID: 6734126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of idiopathic pulmonary fibrosis with colchicine].
    Undurraga A; Meneses M; Sabbagh E; OyarzĂșn M
    Rev Med Chil; 1998 Nov; 126(11):1345-53. PubMed ID: 10349178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of idiopathic pulmonary fibrosis].
    Dury S
    Rev Mal Respir; 2006 Apr; 23(2 Pt 2):5S87-5S91. PubMed ID: 16788517
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacologic therapy of idiopathic pulmonary fibrosis.
    Egan J
    J Heart Lung Transplant; 1998 Nov; 17(11):1039-44. PubMed ID: 9855441
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical and morphological diagnosis of chronic inflammatory lung diseases].
    Borisov SE; Solov'eva IP; Kupavtseva EA; Goncharova EV
    Probl Tuberk Bolezn Legk; 2003; (11):42-55. PubMed ID: 14689798
    [No Abstract]   [Full Text] [Related]  

  • 15. Current perspectives on the treatment of idiopathic pulmonary fibrosis.
    Walter N; Collard HR; King TE
    Proc Am Thorac Soc; 2006 Jun; 3(4):330-8. PubMed ID: 16738197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and management of idiopathic pulmonary fibrosis: Implications for respiratory care.
    Hospenthal MA
    Respir Care; 2006 Apr; 51(4):382-91. PubMed ID: 16563193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surfactant protein-A in lung lavage fluid obtained from patients with idiopathic pulmonary fibrosis.
    Behera D; Kaur S; Sathyanarayana G; Majumdar S
    J Assoc Physicians India; 2002 Nov; 50():1409-12. PubMed ID: 12583473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma.
    Hoyles RK; Ellis RW; Wellsbury J; Lees B; Newlands P; Goh NS; Roberts C; Desai S; Herrick AL; McHugh NJ; Foley NM; Pearson SB; Emery P; Veale DJ; Denton CP; Wells AU; Black CM; du Bois RM
    Arthritis Rheum; 2006 Dec; 54(12):3962-70. PubMed ID: 17133610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of idiopathic pulmonary fibrosis: is there anything new?
    Abdelaziz MM; Samman YS; Wali SO; Hamad MM
    Respirology; 2005 Jun; 10(3):284-9. PubMed ID: 15955138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of pulmonary function in interstitial lung disease].
    Fukuchi Y; Ishida K; Marumo K; Homma S
    Nihon Rinsho; 1990 Mar; 48(3):497-502. PubMed ID: 2355482
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.